Metastatic Triple Negative Breast Cancers

DBCOND0142223NeoplasmsSkin and Subcutaneous Tissue Diseases

Metastatic Triple Negative Breast Cancers is the indication for 3 drugs in DrugBank. It is covered by 14 curated, structured indications.

Also known as
Triple Negative Metastatic Breast Cancer · Metastatic Triple Negative Breast Cancer · Triple-negative Metastatic Breast Cancer · Metastatic Triple-negative Breast Cancer · Metastatic Triple-Negative Breast Carcinoma
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0583085SNOMED CT706970001MedDRA10075566UMLSC3539878

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
14Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
92Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Metastatic Triple Negative Breast Cancers share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In